Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Clonal Anergy | 4 | 2013 | 32 | 1.120 |
Why?
|
| Early Growth Response Protein 2 | 3 | 2017 | 17 | 0.890 |
Why?
|
| T-Lymphocytes | 6 | 2014 | 1275 | 0.690 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2012 | 106 | 0.400 |
Why?
|
| Insulin Receptor Substrate Proteins | 3 | 2010 | 56 | 0.390 |
Why?
|
| Diacylglycerol Kinase | 1 | 2012 | 5 | 0.380 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2009 | 123 | 0.370 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 959 | 0.330 |
Why?
|
| Smad3 Protein | 1 | 2010 | 25 | 0.330 |
Why?
|
| Smad2 Protein | 1 | 2010 | 24 | 0.320 |
Why?
|
| Insulin Resistance | 2 | 2010 | 379 | 0.320 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 122 | 0.320 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2009 | 46 | 0.300 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 347 | 0.270 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 1516 | 0.270 |
Why?
|
| Tumor Microenvironment | 4 | 2017 | 554 | 0.250 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 1980 | 0.220 |
Why?
|
| Obesity | 1 | 2009 | 1019 | 0.190 |
Why?
|
| Mice, Knockout | 5 | 2014 | 2121 | 0.170 |
Why?
|
| Mice, Transgenic | 4 | 2013 | 1584 | 0.170 |
Why?
|
| Mice | 10 | 2017 | 12233 | 0.160 |
Why?
|
| CD28 Antigens | 2 | 2013 | 94 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2013 | 424 | 0.160 |
Why?
|
| Animals | 14 | 2017 | 28041 | 0.160 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2013 | 288 | 0.160 |
Why?
|
| Lymphocyte Activation | 4 | 2013 | 797 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 885 | 0.150 |
Why?
|
| Base Sequence | 2 | 2013 | 2209 | 0.150 |
Why?
|
| Phosphoproteins | 2 | 2010 | 259 | 0.130 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2017 | 17 | 0.130 |
Why?
|
| Signal Transduction | 5 | 2012 | 3498 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 6 | 2017 | 3430 | 0.120 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 156 | 0.110 |
Why?
|
| Phosphorylation | 4 | 2013 | 1130 | 0.110 |
Why?
|
| Antigens, CD | 1 | 2017 | 476 | 0.110 |
Why?
|
| Immunoblotting | 2 | 2012 | 273 | 0.110 |
Why?
|
| Antigens, Neoplasm | 1 | 2017 | 356 | 0.110 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2014 | 22 | 0.110 |
Why?
|
| Melanoma, Experimental | 1 | 2014 | 112 | 0.100 |
Why?
|
| Interferon-beta | 1 | 2014 | 127 | 0.100 |
Why?
|
| Gene Targeting | 1 | 2013 | 74 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 660 | 0.090 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2012 | 27 | 0.090 |
Why?
|
| Luciferases | 1 | 2012 | 129 | 0.090 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 147 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 353 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 139 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2014 | 291 | 0.090 |
Why?
|
| Eye | 1 | 2012 | 109 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2013 | 2828 | 0.090 |
Why?
|
| DNA Primers | 1 | 2012 | 528 | 0.090 |
Why?
|
| Intraoperative Awareness | 1 | 2011 | 2 | 0.090 |
Why?
|
| Consciousness Monitors | 1 | 2011 | 3 | 0.090 |
Why?
|
| Pulmonary Alveoli | 1 | 2011 | 71 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2012 | 947 | 0.080 |
Why?
|
| Phospholipase C gamma | 1 | 2010 | 14 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2012 | 712 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2012 | 884 | 0.080 |
Why?
|
| Anesthetics, Inhalation | 1 | 2011 | 102 | 0.080 |
Why?
|
| Monitoring, Intraoperative | 1 | 2011 | 114 | 0.080 |
Why?
|
| Mice, 129 Strain | 1 | 2010 | 56 | 0.080 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2010 | 51 | 0.080 |
Why?
|
| Binding Sites | 1 | 2013 | 1128 | 0.080 |
Why?
|
| Anesthesia, General | 1 | 2011 | 128 | 0.080 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 217 | 0.080 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2010 | 69 | 0.080 |
Why?
|
| Enzyme Inhibitors | 2 | 2010 | 639 | 0.080 |
Why?
|
| Ubiquitination | 1 | 2010 | 78 | 0.080 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2010 | 109 | 0.080 |
Why?
|
| Caloric Restriction | 1 | 2009 | 13 | 0.080 |
Why?
|
| Rats, Zucker | 1 | 2009 | 38 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2013 | 364 | 0.080 |
Why?
|
| Immunological Synapses | 1 | 2009 | 5 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 454 | 0.070 |
Why?
|
| RNA Interference | 1 | 2010 | 379 | 0.070 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2009 | 44 | 0.070 |
Why?
|
| Protein Binding | 1 | 2013 | 1528 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2010 | 523 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2010 | 281 | 0.070 |
Why?
|
| beta Catenin | 1 | 2010 | 265 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 304 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2010 | 775 | 0.070 |
Why?
|
| Isoenzymes | 1 | 2009 | 271 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 2889 | 0.070 |
Why?
|
| Protein Kinase C | 1 | 2009 | 261 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2010 | 1735 | 0.070 |
Why?
|
| Membrane Proteins | 2 | 2012 | 1260 | 0.070 |
Why?
|
| Fibroblasts | 1 | 2010 | 752 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2013 | 761 | 0.060 |
Why?
|
| Glucose | 1 | 2010 | 692 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 66 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 75 | 0.060 |
Why?
|
| Neoplasms | 2 | 2013 | 3171 | 0.060 |
Why?
|
| Gene Expression | 1 | 2010 | 1302 | 0.060 |
Why?
|
| Liver | 1 | 2009 | 1207 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 2302 | 0.050 |
Why?
|
| Rats | 1 | 2009 | 4042 | 0.050 |
Why?
|
| Proteins | 1 | 2008 | 800 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 2017 | 1389 | 0.040 |
Why?
|
| Male | 3 | 2011 | 44578 | 0.040 |
Why?
|
| CHO Cells | 2 | 2010 | 187 | 0.030 |
Why?
|
| Cytokines | 2 | 2013 | 863 | 0.030 |
Why?
|
| Cricetinae | 2 | 2010 | 532 | 0.030 |
Why?
|
| Hepatocytes | 2 | 2010 | 129 | 0.030 |
Why?
|
| Humans | 6 | 2013 | 93615 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2012 | 1115 | 0.030 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2017 | 31 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2017 | 244 | 0.030 |
Why?
|
| Cell Line | 2 | 2012 | 2459 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2017 | 460 | 0.030 |
Why?
|
| Lymphocyte Depletion | 1 | 2014 | 102 | 0.030 |
Why?
|
| Female | 3 | 2017 | 48779 | 0.030 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2013 | 73 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2013 | 160 | 0.020 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2014 | 188 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2013 | 215 | 0.020 |
Why?
|
| Pericytes | 1 | 2012 | 14 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2014 | 287 | 0.020 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2012 | 10 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 33 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2012 | 60 | 0.020 |
Why?
|
| B7-H1 Antigen | 1 | 2014 | 305 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2013 | 351 | 0.020 |
Why?
|
| Cell Division | 1 | 2013 | 690 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2013 | 554 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2011 | 159 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 691 | 0.020 |
Why?
|
| Coxsackie and Adenovirus Receptor-Like Membrane Protein | 1 | 2010 | 12 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2010 | 74 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 408 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2010 | 43 | 0.020 |
Why?
|
| Cricetulus | 1 | 2010 | 122 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 373 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 701 | 0.020 |
Why?
|
| Protein Kinase C-theta | 1 | 2009 | 16 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 136 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 306 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 2756 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2010 | 463 | 0.020 |
Why?
|
| Cell Movement | 1 | 2010 | 804 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2011 | 797 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 2020 | 0.020 |
Why?
|
| Flavonoids | 1 | 2006 | 85 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 990 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 392 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 1610 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2011 | 4565 | 0.010 |
Why?
|
| Risk Factors | 1 | 2011 | 5912 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2011 | 2564 | 0.010 |
Why?
|
| Aged | 1 | 2011 | 20469 | 0.010 |
Why?
|
| Middle Aged | 1 | 2011 | 27621 | 0.010 |
Why?
|
| Adult | 1 | 2011 | 27955 | 0.010 |
Why?
|